Travel Time May Hamper Follow-Up Chemo.
Travel Time May Hamper Follow-Up Chemo, Study Says: – MONDAY, Aug. 24, 2015 – – The farther they have to travel, the less likely cancer individuals are to receive follow-up chemotherapy after surgery, a fresh study finds. This kind of treatment, called adjuvant chemotherapy, is recommended for most patients after surgery to lessen the opportunity of cancer returning http://aygestin.org/user-reviews-on-aygestin-norethisterone.html . This study viewed nearly 34,700 patients over the USA who had surgery for colon cancer, and found that nearly 76 % received adjuvant chemotherapy within 3 months of surgery.
Green: Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2 The myeloproliferative neoplasms are chronic myeloid cancers that are characterized by the overproduction of mature blood cells, and that may evolve into acute myeloid leukemia.1,2 In addition to chronic myeloid leukemia with the BCR-ABL fusion gene, the three most common myeloproliferative neoplasms are crucial thrombocythemia, polycythemia vera, and myelofibrosis.3-6 The JAK2 V617F mutation or JAK2 exon 12 mutations are found in most individuals with polycythemia vera,7,8 whereas the JAK2 V617F mutation is found in just 50 to 60 percent of individuals with essential thrombocythemia or myelofibrosis.9,10 Checks for JAK2 mutations possess greatly simplified the diagnosis of myeloproliferative neoplasms and so are now firmly embedded as front-line tests in national and international guidelines.11-14 However, distinguishing essential thrombocythemia with nonmutated JAK2 from the a lot more common reactive thrombocytosis remains a significant diagnostic challenge.